5 therapeutic pharmaceutical preparations for the treatment of skeletal diseases, connective tissue diseases, neurological diseases, urological diseases, kardiovascular diseases, dermatological diseases, liver diseases, autoimmune diseases; diagnostic reagents for medical or clinical laboratory use; live bones of any type and origin and live bone cells for subsequent implantation and transplantation; live tissue transplants and implants, namely, stemm cells, connective tissue, reproductive tissue, bone cells, skin cells, neuronal cells, smooth muscle cells, myofibroblasts, liver cells, epithelial cells, endothelial cells; support materials for bone cell transplants as pharmaceutical preparations, namely, organic and inorganic materials of synthetic and natural origin, namely, synthetic organic materials as poly (alpha-hydroxy-acids), polyethylene glycol, polyesters, polyuerethans, gelatine, alginates, resins, synthetic inorganic materials as hydroxyapatit, tricalcium phosphate, plaster of Paris, titanium, silicon, siloxanes, silanes, glass, ceramics, organic materials of natural origin as collagen, fibrin, bone extracts, cellulose, inorganic materials of natural origin as coralline hydroxyapatite, bovine bone matrix